1 SURVEY
LIVE

Serial Number

79357619

Owner

1MED SA

Attorney

MICHELLE E. TOCHTROP

Filing Date

Sep 15, 2022

Add to watchlist:

No watchlists yet
View on USPTO

1 SURVEY Trademark

Serial Number: 79357619 • Registration: 7435298

1 SURVEY is a trademark filed by 1MED SA on September 15, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

1MED SA (4 trademarks)

Via Campagna 13

Entity Type: 99

Trademark Details

Filing Date

September 15, 2022

Registration Date

July 9, 2024

Published for Opposition

April 23, 2024

Goods & Services

Downloadable computer software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; Downloadable computer application software for mobile phones, tablets, handheld computers, namely, software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; downloadable specialized software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; downloadable collaborative software, namely software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; Downloadable communication software to access data stored on an oximeter and transfer data to another device; downloadable file sharing software; downloadable document management software; downloadable software for management of data, files and databases; downloadable software for process control of Quality Management Systems (QMS); downloadable data processing software; downloadable computer software for managing the product life cycles of others; downloadable industrial process management software; downloadable software for production process monitoring, analysis, control and operation of medical devices, scientific equipment, clinical trials; downloadable software for verification of the regulatory compliance of goods; downloadable software for monitoring the regulatory compliance of clinical trials; downloadable software for quality control in the field of medical devices and the pharmaceutical industry; downloadable software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials

Providing access to and rental of access time to a database of third parties; providing access to data or documents in electronic format on centralized files for remote consultation; providing online access to platforms and portals on the Internet; electronic transmission of messages, data and documents

Website hosting services; software as a service (SAAS) services, namely, software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; rental of computer software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; development, programming and implementation of computer software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials; development, programming and implementation of data processing software; development, programming and implementation of software for checking the regulatory compliance of goods; development, programming and implementation of software for quality control of goods and clinical studies; quality control consultation services for others; analysis and assessment of product design in the field of medical devices and the pharmaceutical industry; non-downloadable computer software used to perform qualitative assessment of the performance of pharmaceuticals, medical products and medical devices; providing information on product development for others; non- downloadable computer software used to perform preliminary assessment services in the field of new pharmaceuticals, medical products and medical devices; pharmaceutical research and development consultation services; consultation services on product development of others in the field of medical devices and the pharmaceutical industry; providing information on the results of product development clinical trials for pharmaceuticals, medical products and medical devices; design and development of medical technologies for others; design and development of analytical methods and tests for others; research and development services in the field of medical devices and pharmaceuticals; scientific and technological design services; conducting of scientific feasibility studies for others; conducting technical feasibility studies for others; conducting scientific feasibility studies with respect to product design; conducting scientific feasibility studies with respect to the analysis of materials in the field of medical devices, pharmaceuticals, parapharmaceuticals; conducting scientific feasibility studies in the field of clinical trials; planning and conducting scientific pre-clinical and clinical studies; providing medical and scientific research information of pharmaceuticals and clinical trials; conducting scientific clinical trials and research for third parties; conducting clinical trials for others in the field of pharmaceuticals, medical products and medical apparatus; providing scientific research information in the field of clinical trials; pharmaceutical research and development; research of technical projects in the field of medical devices and the pharmaceutical industry; assessment of chemical information in relation to risks; assessment of toxicological information in relation to risks; development of customized software for others for use in risk assessment in the field of medical devices and the pharmaceutical industry; development of customized software for others for the scientific assessment of risks; analytical laboratory services; laboratory research services relating to pharmaceuticals, medical devices and medical products; scientific laboratory services; advisory services with respect to laboratory tests; diagnostic services for others for scientific research purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 14, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 14, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 9, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 11, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 15, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 15, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
NOTIFICATION PROCESSED BY IB
Apr 23, 2024 GPNX
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 3, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 20, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 20, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 20, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 20, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2024 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 7, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 7, 2023 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 1, 2023 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 1, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 30, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 23, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 16, 2022 REPR